ba0006p145 | (1) | ICCBH2017
Joseph S
, Capaldi N
, DiMarco M
, Dunne J
, Horrocks I
, Shepherd S
, Ahmed S F
, Wong S C
Background: There is still limited information on changes in growth especially segmental growth and bone mass of glucocorticoid(GC) treated boys with Duchenne Muscular Dystrophy (DMD).Objectives: To evaluate changes in growth and bone mass in GC treated boys with DMD.Methods: Retrospective study of 15 boys with DMD treated with GC, median age 7.6 years (4.1, 15.5) who had repeated DXA scan for clinical monitoring of bone health, me...